Market cap
$3 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -23.42 | -- | -- |
| EBIT | 64.57 | 61.54 | 0.93 | -8.20 | -246.55 |
| Net Profit | 68.04 | 65.11 | 2.20 | -7.76 | -247.08 |
| EPS | 68.55 | 65.67 | 2.35 | 14.15 | -- |
| Book Value | -- | -- | -64.69 | -55.75 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-24 | Dec-23 |
| EBIT-Margin
| -- | -- | -10,372.35 | -- | -- |
| Net Margin
| -4,637.12 | -4,637.12 | -10,394.00 | -- | -- |
| Return on equity
| -70.01 | -480.18 | -646.46 | -106.00 | -63.29 |
| Return on Capital
| -68.66 | -103.03 | -- | -103.47 | -62.09 |
| Return on Assets
| -60.85 | -80.37 | -107.57 | -87.44 | -56.91 |
| Debt to Equity (x)
| -- | -- | 18.29 | 0.04 | 0.02 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
--
|
-103.47
|
-62.09
|
-40.42
|
-63.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-646.46
Lower than Peers by 606.17
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-646.46
|
-106.00
|
-63.29
|
-40.74
|
-63.28
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
-107.57
Lower than Peers by 76.73
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-107.57
|
-87.44
|
-56.91
|
-38.20
|
-59.56
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
-10,372.35
Lower than Peers by 10,290.14
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-10,372.35
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
-10,394.00
Lower than Peers by 10,304.12
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-10,394.00
|
--
|
--
|
-4,637.12
|
--
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
Lower than Peers by 0.01
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-23.42
Lower than Peers by 77.46
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-23.42
|
--
|
--
|
--
|
--
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
0.93
Higher than Peers by 1.88
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
0.93
|
-10.34
|
-21.96
|
-3.61
|
-202.81
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
2.20
Higher than Peers by 9.39
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
2.20
|
-10.93
|
-20.47
|
-5.27
|
-463.69
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
EPS Growth
2.35
Lower than Peers by 12.08
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
2.35
|
-0.11
|
0.47
|
0.06
|
-1.53
|
|
Peer Median
|
14.43
|
--
|
--
|
--
|
--
|
Book Value Growth
-98.76
Lower than Peers by 88.30
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-98.76
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.46
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
18.29
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
18.29
|
0.04
|
0.02
|
0.02
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.86
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
0.86
|
0.02
|
0.00
|
0.00
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.01
Lower than Peers by 3.79
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
2.01
|
3.33
|
9.37
|
13.88
|
21.52
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
2.01
Lower than Peers by 3.68
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
2.01
|
--
|
--
|
14.03
|
21.72
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
-77.41
Lower than Peers by 75.32
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
-77.41
|
--
|
-28,410.33
|
-231.40
|
-186.84
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
116.59
Higher than Peers by 97.61
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
116.59
|
--
|
--
|
--
|
--
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
0.01
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
--
|
--
|
-740.65
|
-1,225.62
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
--
|
1,836.79
|
1,904.03
|
2,682.56
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
--
|
-0.63
|
-1.44
|
-0.93
|
-2.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.65
Lower than Peers by 4.70
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
0.65
|
1.29
|
0.93
|
0.48
|
0.78
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
1.36
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
1.36
|
-0.03
|
0.20
|
1.06
|
0.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
3
Lower than Peers by 144
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
IO Biotech Inc (IOBT)
|
3
|
--
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|